Medicare Increases Coverage of TMS Therapy for Depression
A recent change in Medicare coverage will now make transcranial magnetic stimulation (TMS) therapy for depression much more accessible. After seeing the significant improvements in patients with treatment resistant depression along with its non-invasive nature and minimal side effects, Medicare will now cover TMS for patients with severe depression after failing just one antidepressant medication. […]
Stephen Manlove, MD is one of the most entrepreneurial psychiatrists in the upper Midwest. Dr. Manlove graduated from the University of Minnesota Medical School and completed residencies in Psychiatry and Internal Medicine through the University of Virginia Medical School. He holds multiple board certifications in psychiatry/neurology, internal medicine and forensic psychiatry. This deep understanding of medicine gives him a unique ability to practice truly holistic psychiatry—fusing lifestyle changes and brain health best practices with genetic testing and a detailed laboratory workup to develop a personalized plan for each patient. As an early adopter of transcranial magnetic stimulation (TMS) and ketamine/Spravato, he and the Manlove Brain + Body team have helped thousands of patients suffering from treatment resistant depression, anxiety and PTSD.